Related Articles
Neoadjuvant apatinib plus tegafur/gimeracil/oteracil potassium (S‑1)/oxaliplatin chemotherapy vs. chemotherapy alone in patients with locally advanced gastric carcinoma
Efficacy and safety of camrelizumab (a PD‑1 inhibitor) combined with chemotherapy as a neoadjuvant regimen in patients with locally advanced non‑small cell lung cancer
Addition of oxaliplatin to capecitabine‑based preoperative chemoradiotherapy for locally advanced rectal cancer: Long‑term outcome of a phase II study
Neoadjuvant immune checkpoint inhibitor treatment + chemotherapy (vs. chemotherapy alone) for locally advanced non‑small cell lung cancer: A retrospective cohort study
Efficacy and safety of XELOX and FOLFOX6 adjuvant chemotherapy following radical total gastrectomy